A new therapeutical approach : Topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy with paclitaxel and platinum
スポンサーリンク
概要
- 論文の詳細を見る
- 2003-06-01
著者
-
Stengel Dirk
Clinical Epidemiology Working Group Department Of Tranma Surgery Ernst-moritz-arndt University
-
LICHTENEGGER Werner
Department of Gynaecology, Charite/Campus Virchow Hospital, Medical Faculty of the Humboldt-Universi
-
Sehouli Jalid
Department Of Gynaecology Charite/campus Virchow Hospital Medical Faculty Of The Humboldt-university
-
Sehouli Jalid
Department Of Gynecology And Obstetrics Charite/campus Virchow-klinikum Humboldt-university
-
OSKAY Gulten
Department of Gynecology and Obstetrics, Charite/Campus Virchow-Klinikum, Humboldt-University
-
BLOHMER Jens
Department of Gynecology and Obstetrics, Charite/Campus Virchow-Klinikum, Humboldt-University
-
KAUBITZSCH Sabine
Department of Gynecology and Obstetrics, Charite/Campus Virchow-Klinikum, Humboldt-University
-
Lichtenegger Werner
Department Of Gynaecology Charite/campus Virchow Hospital Medical Faculty Of The Humboldt-university
-
Lichtenegger Werner
Department Of Gynecology And Obstetrics Charite/campus Virchow-klinikum Humboldt-university
-
Blohmer Jens
Department Of Gynecology And Obstetrics Charite/campus Virchow-klinikum Humboldt-university
-
Oskay Gulten
Department Of Gynecology And Obstetrics Charite/campus Virchow-klinikum Humboldt-university
-
Kaubitzsch Sabine
Department Of Gynecology And Obstetrics Charite/campus Virchow-klinikum Humboldt-university
関連論文
- Operative Results after Primary and Secondary Debulking-Operations in Advanced Ovarian Cancer (AOC)
- A new therapeutical approach : Topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy with paclitaxel and platinum
- How Much Radicality Do We Need In The Surgery Of Ovarian Cancer?